CompaniesByCap
AVTX
Avalo Therapeutics Inc. (AVTX)
NASDAQ · Healthcare

Avalo Therapeutics Inc. Cash Flow 2015–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Operating Activities
Operating Cash Flow-51.5M-49.1M-30.7M-26.8M-70.9M-40.5M-19.1M-3.1M12.6M-14.6M-10.2M
Depreciation & Amort.344,000169,000158,000166,0001.7M1.8M3.9M4.6M425,47626,85623,508
Investing Activities
Capital Expenditure95,000113,00063,000262,013564,41523,32534,88319,984
Free Cash Flow-26.8M-71.0M-40.6M-19.4M-3.7M12.6M-14.6M-10.2M
Financing Activities
Dividends Paid
Stock Buybacks

Avalo Therapeutics Inc. Cash Flow — FAQ

Avalo Therapeutics Inc. (AVTX) cash flow over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AVTX's cash flow history?

The chart and table above show Avalo Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.